BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 6203405)

  • 1. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
    Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
    Creager MA; Halperin JL; Bernard DB; Faxon DP; Melidossian CD; Gavras H; Ryan TJ
    Circulation; 1981 Sep; 64(3):483-9. PubMed ID: 6266691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease.
    Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ
    Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional circulatory response to converting-enzyme inhibition in congestive heart failure.
    Faxon DP; Creager MA; Halperin JL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):179S-186S. PubMed ID: 6753899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary and renal circulation in patients with cardiac failure after converting enzyme inhibitors].
    Juliard JM; Dahan M; Solal AC; Merillon JP; Gourgon R
    Presse Med; 1985 Dec; 14(44):2260-3. PubMed ID: 3003731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit.
    Ohmae M; Rabkin SW; Fung HY
    J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure dependence of renal hemodynamics and function during converting-enzyme inhibition in congestive heart failure.
    Ribstein J; de Treglode D; Mimran A
    Contrib Nephrol; 1984; 41():43-6. PubMed ID: 6098416
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    Hypertension; 1983; 5(3):312-20. PubMed ID: 6188693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
    Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
    J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.